Valuation: Kintor Pharmaceutical Limited

Market Cap 84Cr 98Cr 12Cr 11Cr 10Cr 9.34Cr 18Cr 1.19TCr 18Cr 122.88Cr 47Cr 608.55Cr 47Cr 46Cr 1.96TCr P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 89Cr 104.08Cr 13Cr 12Cr 11Cr 9.95Cr 19Cr 1.27TCr 19Cr 130.8Cr 50Cr 647.79Cr 50Cr 49Cr 2.09TCr EV / Sales 2024
7,57,94,130x
EV / Sales 2025 2,82,45,180x
Free-Float
88.01%
Yield 2024 *
-
Yield 2025 -
1 day+4.21%
1 week+3.12%
Current month+15.79%
1 month+9.70%
3 months-12.00%
6 months-34.00%
Current year+1.02%
1 week 1.8
Extreme 1.8
2.05
1 month 1.6
Extreme 1.6
2.05
Current year 1.6
Extreme 1.6
4.7
1 year 1.6
Extreme 1.6
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
72.7
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 24/03/2009
Director of Finance/CFO 48 21/09/2026
Chief Tech/Sci/R&D Officer 49 01/09/2020
Director TitleAgeSince
Director/Board Member 62 12/08/2019
Director/Board Member 61 12/08/2019
Chairman 64 24/03/2009
Date Insider Type Main position Quantity % Market Cap. Importance
17/07/26 Other

Chief Executive Officer

1,45,000 0.0291%
21/05/26 Other

Chief Executive Officer

38,000 0.0076%
18/05/26 Other

Chief Executive Officer

1,70,000 0.0341%
Change 5-day change 1-year change 3-year change Capi.($)
+4.21%+3.12%-26.12%-28.52% 12Cr
-0.07%+5.66%+54.34%+113.69% 7.43TCr
-1.45%-1.43%+36.82%+80.62% 6.23TCr
-0.66%+7.14%+39.36%+29.20% 2.77TCr
-0.15%-3.58%-16.54%+358.69% 2.64TCr
+2.93%+2.03%+4.83%-5.22% 2.46TCr
+0.84%+7.70%+26.09%-10.70% 2.07TCr
+0.87%-2.52%+151.81%+328.17% 1.5TCr
+1.63%+3.45%+45.01%+169.46% 1.42TCr
+1.30%-7.06%-9.37%+835.52% 1.35TCr
Average +0.99%+0.56%+30.62%+187.09% 2.79TCr
Weighted average by Cap. +0.13%+2.10%+37.41%+150.60%

Financials

2024 2025
Net sales 5 5.85 0.75 0.65 0.61 0.56 1.05 71.34 1.05 7.36 2.84 36.43 2.8 2.74 117.45 32.68 38.26 4.88 4.26 4.01 3.66 6.86 466.31 6.86 48.08 18.55 238.13 18.32 17.92 767.69
Net income -16Cr -18Cr -2.32Cr -2.03Cr -1.9Cr -1.74Cr -3.26Cr -221.57Cr -3.26Cr -23Cr -8.82Cr -113.15Cr -8.7Cr -8.51Cr -364.78Cr -20Cr -23Cr -2.99Cr -2.61Cr -2.45Cr -2.24Cr -4.2Cr -285.51Cr -4.2Cr -29Cr -11Cr -145.81Cr -11Cr -11Cr -470.05Cr
Net Debt -1.57Cr -1.84Cr -23.4L -20.45L -19.22L -17.54L -32.92L -22Cr -32.93L -2.31Cr -89.02L -11Cr -87.89L -85.96L -37Cr 5.39Cr 6.31Cr 80.39L 70.25L 66.03L 60.25L 1.13Cr 77Cr 1.13Cr 7.92Cr 3.06Cr 39Cr 3.02Cr 2.95Cr 126.52Cr
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
122
Date Price Change Volume
22/26/22 HK$1.980 +4.21% 11,05,500
21/26/21 HK$1.900 +4.40% 5,24,000
18/26/18 HK$1.820 -3.70% 8,64,000
17/26/17 HK$1.890 +0.53% 7,71,500
16/26/16 HK$1.880 0.00% 2,32,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!